Associated tags: Finance, Health, Oxford, Professional Services, Practice Management, Financial services, Patient, Nursing
Locations: OXFORD, LONDON, GB, ALABAMA, ILLINOIS, PENNSYLVANIA, FLORIDA, WEST VIRGINIA, VIRGINIA, CALIFORNIA, TEXAS, UNITED STATES, NORTH AMERICA, LOS ANGELES, SAN DIEGO
Retrieved on:
Tuesday, January 16, 2024
Construction & Property,
Finance,
Hospitals,
REIT,
Professional Services,
Managed Care,
Health,
General Health,
Asset Management,
Partnership,
Bed,
Acquisition,
Healthcare real estate,
Growth,
Bank Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare companies worldwide, is pleased to announce that its Healthcare Real Estate and ABL Group continued its stable growth in 2023, with Oxford providing over $430 million of capital commitments.
Key Points:
- Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare companies worldwide, is pleased to announce that its Healthcare Real Estate and ABL Group continued its stable growth in 2023, with Oxford providing over $430 million of capital commitments.
- The group closed a total of 11 transactions ranging in size from $2.0 million to $89.0 million.
- Select transactions completed in 2023 include:
Texas Revolving Line of Credit: Oxford provided a $14.25 million revolving line of credit to finance working capital needs for 29 skilled nursing facilities for an expanding Texas-based operator.
- The credit facility also includes an accordion feature that would allow the borrower to increase the line limit to $27.25 million.
Hercules,
VRNA,
Health care,
COPD,
Chronic obstructive pulmonary disease,
Pharming,
Growth,
Patient,
Pharma,
Creditor,
Senior LONDON and RALEIGH, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), announces it and its wholly-owned subsidiary, Verona Pharma, Inc. (the “Company”), have entered into a debt financing facility (“debt facility”) providing the Company with access to up to $400 million from funds managed by Oxford Finance LLC (“Oxford”) and Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) (collectively, the “Lenders”).
Key Points:
- LONDON and RALEIGH, N.C., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), announces it and its wholly-owned subsidiary, Verona Pharma, Inc. (the “Company”), have entered into a debt financing facility (“debt facility”) providing the Company with access to up to $400 million from funds managed by Oxford Finance LLC (“Oxford”) and Hercules Capital, Inc. (NYSE: HTGC) (“Hercules”) (collectively, the “Lenders”).
- The debt facility replaces the existing facility of up to $150 million with an affiliate of Oxford.
- Verona Pharma will pay only interest on the outstanding loans under the debt facility for the first 53 months with the outstanding principal of the loans under the debt facility amortized over the subsequent 7 months.
- The $20 million drawn and fees and associated costs due to Oxford on the discharge of the existing debt facility will be paid to Oxford on closing of the debt facility.
Seniors,
Practice Management,
Nursing,
Finance,
General Health,
Health,
Professional Services,
Consumer,
Acquisition,
Oxford,
Bed,
Chinese Estates Group,
Financial services,
Bank Oxford Finance LLC (“Oxford”), a leading specialty firm that provides senior debt to life sciences and healthcare companies worldwide is pleased to announce that its Healthcare Real Estate Group closed a strong first half of 2023, providing total capital commitments of approximately $200 million in six transactions.
Key Points:
- Oxford Finance LLC (“Oxford”), a leading specialty firm that provides senior debt to life sciences and healthcare companies worldwide is pleased to announce that its Healthcare Real Estate Group closed a strong first half of 2023, providing total capital commitments of approximately $200 million in six transactions.
- As increasing interest rates and challenges in the traditional banking sector have strained capital availability, Oxford Finance remains committed to providing customized, relationship-driven solutions to the healthcare real estate market, with an active pipeline for the remainder of 2023.
- Select transactions completed in H1-2023 include:
Texas Revolving Line of Credit: Oxford provided a $14.25 million revolving line of credit to finance working capital needs for 29 skilled nursing facilities for an expanding Texas-based operator.
- The credit facility also includes an accordion feature that would allow the borrower to increase the line limit to $27.25 million.
Professional Services,
Mental Health,
Health,
Telemedicine,
Virtual Medicine,
Health Technology,
Finance,
EAP,
Oxford,
Sequoia,
Mindfulness,
Cigna,
Organization,
Pulse,
Happiness,
Accolade,
Meditation,
Ecosystem,
Mental health,
Psychiatry,
Nursing,
Headspace Oxford Finance (“Oxford”), a leading specialty finance firm providing senior debt to healthcare and life sciences companies worldwide, is pleased to announce the closing of a $105 million senior debt facility with Headspace (“the Company”), a pioneering digital healthcare company.
Key Points:
- Oxford Finance (“Oxford”), a leading specialty finance firm providing senior debt to healthcare and life sciences companies worldwide, is pleased to announce the closing of a $105 million senior debt facility with Headspace (“the Company”), a pioneering digital healthcare company.
- Additionally, the investment will enable the Company to be opportunistic in investing in areas where it sees market need.
- "We are thrilled to partner with Headspace, a company at the forefront of revolutionizing care for mental health,” said Rohit Gandhi, senior director at Oxford.
- "We’re excited to partner with Oxford and grateful for their confidence in our vision,” said Russell Glass, chief executive officer of Headspace.
Technology,
Finance,
Health Technology,
Professional Services,
Health Insurance,
Software,
Practice Management,
General Health,
Health,
Data Management,
Management,
Amine Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare and life sciences companies worldwide, is pleased to announce it recently provided a $42 million senior debt facility to Amino Health (“Amino”), a rapidly growing digital health company.
Key Points:
- Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare and life sciences companies worldwide, is pleased to announce it recently provided a $42 million senior debt facility to Amino Health (“Amino”), a rapidly growing digital health company.
- The senior debt facility will enable Amino to accelerate its growth plans, enhance its technology infrastructure, and expand its market reach.
- This injection of capital will also allow Amino to further strengthen its team and continue to attract top talent in the industry.
- William Blair acted as the exclusive financial advisor to Amino Health in connection with its investment from Oxford Finance LLC.
Nursing,
Finance,
Seniors,
Professional Services,
Practice Management,
Other Health,
Health,
Consumer,
Other Professional Services,
Maintenance,
Partnership,
Histology,
Oxford,
Pathology,
NMS,
Acquisition,
Investment,
Engineering,
Financial services,
Hospital Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Leveraged Lending Group closed a strong first half of 2023, providing approximately $1 billion of commitments across 13 new platform investments and supporting multiple follow-on investments by portfolio companies.
Key Points:
- Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Leveraged Lending Group closed a strong first half of 2023, providing approximately $1 billion of commitments across 13 new platform investments and supporting multiple follow-on investments by portfolio companies.
- Select transactions completed in H1-2023 include:
June 2023: Oxford acted as the administrative agent in the funding of a senior credit facility to finance the buyout of a specialty third-party administrator of medical insurance products by a middle market private equity sponsor.
- May 2023: Oxford acted as the administrative agent in the funding of a senior credit facility to finance the majority recapitalization of a leading outsourced electronics-focused design, engineering, and product manufacturer to the medical device and life sciences industries by EW Healthcare Partners.
- February 2023: Oxford acted as the administrative agent in the funding of a senior credit facility for the acquisition of a healthcare digital marketing company providing proprietary technology-enabled solutions by Amulet Capital Partners.
Apps,
Applications,
Technology,
Health Technology,
Telemedicine,
Virtual Medicine,
Health Insurance,
Software,
Practice Management,
Internet,
Health,
Navigation,
Emerge Commerce,
TIC,
Patient,
WTI,
Growth,
Fine chemical,
Dietary supplement Amino Health , the leading digital healthcare guidance company, today announced $80 million in both equity and debt financing led by Transformation Capital and Oxford Finance LLC, respectively.
Key Points:
- Amino Health , the leading digital healthcare guidance company, today announced $80 million in both equity and debt financing led by Transformation Capital and Oxford Finance LLC, respectively.
- Amino Health has dedicated the last decade to developing a digital navigation experience that intuitively guides members to high-quality, cost-effective care through their unique health plans and benefits.
- As the health technology market exploded with the launch of new solutions, Amino Health steadily grew to support 1.6 million members, with a 97% customer retention rate and a net promoter score of 80+.
- “With their advanced data insights to personalized care recommendations for consumers, Amino Health is unlike any other player in the market.
Retrieved on:
Thursday, February 2, 2023
Seniors,
Practice Management,
Nursing,
Finance,
Health,
Professional Services,
Consumer,
Other Health,
Bed,
Chinese Estates Group,
Acquisition,
Oxford,
Financial services,
Real estate Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Real Estate Group closed a record level of originations in 2022, with Oxford providing over $867 million of capital commitments.
Key Points:
- Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Real Estate Group closed a record level of originations in 2022, with Oxford providing over $867 million of capital commitments.
- The group closed a total of 14 transactions, with credit facilities ranging from $9 million to over $124 million.
- Despite the uncertain economic environment and fluctuating competitive landscape, Oxford Finance remains committed to providing customized, relationship-driven solutions to the healthcare real estate market.
- West Coast Revolving Line of Credit: Oxford supplied a $9.0 million revolving line of credit to finance working capital needs for seven skilled nursing facilities for an expanding California-based operator.
Retrieved on:
Wednesday, November 16, 2022
Professional Services,
Health,
Practice Management,
Other Health,
Dental,
Finance,
Dentistry,
Investment,
Oxford,
Douglas F3D Skyknight,
Partnership,
Entrepreneurship,
Pension,
Health care,
Acquisition,
Pearl Street,
Growth,
Dentist,
Finance,
Patient,
Health,
Healthcare,
Financial services Oxford Finance LLC ("Oxford"), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a $115 million senior credit facility to Pearl Street Dental Partners ("Pearl Street" or "the Company"), a fast-growing dental platform owned by SkyKnight Capital ("SkyKnight"), dentists, and management.
Key Points:
- Oxford Finance LLC ("Oxford"), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a $115 million senior credit facility to Pearl Street Dental Partners ("Pearl Street" or "the Company"), a fast-growing dental platform owned by SkyKnight Capital ("SkyKnight"), dentists, and management.
- With 32 partner practices and over 350 employees, Pearl Street is a leader in Texas and Oklahoma.
- "Pearl Street Dental Partners has developed a strong growth platform with a lengthy track record of successful new partner integrations," said Tracy S. Maziek, Head of Healthcare services at Oxford Finance.
- Headquartered in Dallas, Texas, Pearl Street is a dental practice management company partnering with dental practices throughout Texas and Oklahoma.
Retrieved on:
Monday, November 14, 2022
Atomic mass,
Health,
SNPP,
CKD,
Senior,
NASH,
Company,
SAFE,
Therapy,
Pneumonia,
RCT,
Patient,
End organ damage,
CEO,
Risk,
HIV disease progression rates,
Iron(II) sulfide,
Disease,
Solution,
Pharmaceutical industry,
COVID The term loan matures in October 2027 and includes a 24-month interest only period, which can be extended to 36 months under certain conditions.
Key Points:
- The term loan matures in October 2027 and includes a 24-month interest only period, which can be extended to 36 months under certain conditions.
- The first tranche of $10 million closed in August 2022 and the Company is under no obligation to draw additional funds in the future.
- "This funding provides Renibus with significant strategic and operational flexibility against a challenging external backdrop," said Frank Stonebanks, Chairman and CEO of Renibus.
- Partnering with Oxford offers valuable access to capital that can support the advancement of our product candidates toward the market."
